These data suggest that CK2-mediated Ser81 phosphorylation of PR may activate gene expression programs involved in modulating inflammation related to breast cancer development and progression, including mammary stem cell maintenance and self-renewal. The gene discussed is PGR; the disease is breast carcinoma.